HER2/Neu Positive Active Not Recruiting Phase 1 / 2 Trials for Pertuzumab (DB06366)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01922921Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody TherapyTreatment